ArticleFrontiers in microbiology2026
Non-invasive molecular surveillance of drug-resistant bacterial and fungal pathogens in severe ICU pneumonia: a comparative study of nasopharyngeal swabs and BALF.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Drug-resistant bacterial and fungal infections represent a major cause of morbidity and mortality among critically ill and immunocompromised patients with severe pneumonia. Molecular diagnostics using bronchoalveolar lavage fluid (BALF) are considered the reference standard for pathogen identification but are invasive and often contraindicated in unstable intensive care unit (ICU) patients. Safer non-invasive sampling strategies that maintain diagnostic reliabilityfor clinically relevant and potentially drug-resistant pathogens are therefore urgently needed. Methods: In this prospective cohort study conducted between January 1 and July 30, 2024, paired nasopharyngeal swabs (NPS) and BALF samples were collected from 105 ICU patients with severe pneumonia. Pathogen detection was performed using targeted next-generation sequencing (tNGS) with a focus on clinically significant bacterial, viral, and fungal pathogens commonly associated with antimicrobial resistance. Concordance between NPS and BALF was evaluated using positive percent agreement (PPA) and negative percent agreement (NPA), with BALF serving as the reference standard. Longitudinal two-phase sampling was performed in 74 patients to assess the capacity of NPS to monitor temporal changes in pathogen profiles. Results: Compared with BALF, NPS demonstrated high concordance for major bacterial pathogens frequently associated with drug resistance, including Conclusion: Nasopharyngeal swab-based tNGS represents a feasible and less invasive approach for the early molecular identification of common bacterial pathogens, including those frequently implicated in drug-resistant infections, in patients with severe ICU pneumonia. While NPS may support early antimicrobial decision-making when BALF is not immediately available, its reduced sensitivity for fungal and viral pathogens and limited performance in longitudinal surveillance underscore the continued necessity of BALF for comprehensive infection assessment, particularly in immunocompromised and high-risk ICU populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.